Assembly of multi-subunit fusion proteins into the RNA-targeting type III-D CRISPR-Cas effector complex

Evan A Schwartz,Jack PK Bravo,Luis A Macias,Caitlyn L McCafferty,Tyler L Dangerfield,Jada N Walker,Jennifer S Brodbelt,Peter C Fineran,Robert D Fagerlund,David W Taylor
DOI: https://doi.org/10.1101/2022.06.13.496011
2022-06-16
bioRxiv
Abstract:CRISPR (Clustered regularly interspaced short palindromic repeats)-Cas (CRISPR-associated) systems are a type of adaptive immune response in bacteria and archaea that utilize crRNA (CRISPR RNA)-guided effector complexes to target complementary RNA or DNA for destruction. The prototypical type III-A and III-B CRISPR-Cas systems utilize multi-subunit effector complexes composed of individual proteins to cleave ssRNA targets at 6-nt intervals, as well as non-specifically degrading ssDNA and activating cyclic oligoadenylate (cOA) synthesis. Recent studies have shown that type III systems can contain subunit fusions yet maintain canonical type III RNA-targeting capabilities. To understand how a multi-subunit fusion effector functions, we determine structures of a variant type III-D effector and biochemically characterize how it cleaves RNA targets. These findings provide insights into how multi-subunit fusion proteins are tethered together and assemble into an active and programmable RNA endonuclease, how the effector utilizes a novel mechanism for target RNA seeding, and the structural basis for the evolution of type III effector complexes. Furthermore, our results provide a blueprint for fusing subunits in class 1 effectors for design of user-defined effector complexes with disparate activities.
What problem does this paper attempt to address?